You can access the original SEC filing by clicking here.
Ownership Summary Table
|Name||Sole Voting Power||Shared Voting Power||Sole Dispositive Power||Shared Dispositive Power||Aggregate Amount Owned Power||Percent of Class|
|HealthCor Offshore Master Fund||0||782,520||0||1.9%|
|HealthCor Offshore GP||0||782,520||0||1.9%|
|HealthCor Sanatate Offshore Master Fund||0||492,480||0||1.2%|
|HealthCor Offshore II GP||0||492,480||0||1.2%|
Page 1 of 15 – SEC Filing
SECURITIES & EXCHANGE COMMISSION
Washington, D.C. 20549
INFORMATION TO BE INCLUDED IN STATEMENTS
TO RULES 13d-1(b), (c) AND (d) AND AMENDMENTS
PURSUANT TO RULE 13d-2
(Amendment No. )*
Pacira Pharmaceuticals, Inc.
(Name of Issuer)
(Title of Class of Securities)
(Date of Event Which Requires Filing of
Check the appropriate box to designate the
rule pursuant to which this Schedule is filed:
(Page 1 of 17 Pages)
*The remainder of this cover page shall be
filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent
amendment containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder of
this cover page shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934
(“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions
of the Act (however, see the Notes).